It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
OMCL’s FA Score shows that 0 FA rating(s) are green whileVHIBF’s FA Score has 1 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
OMCL’s TA Score shows that 5 TA indicator(s) are bullish while VHIBF’s TA Score has 3 bullish TA indicator(s).
OMCL (@Services to the Health Industry) experienced а -0.58% price change this week, while VHIBF (@Services to the Health Industry) price change was +3.93% for the same time period.
The average weekly price growth across all stocks in the @Services to the Health Industry industry was +1.49%. For the same industry, the average monthly price growth was -1.17%, and the average quarterly price growth was -0.83%.
OMCL is expected to report earnings on Nov 04, 2025.
This industry comprises companies that provide services, such as equipment sterilization, research, physician management systems and consulting, that support the healthcare/medical industry. Examples of such companies include Laboratory Corporation of America Holdings, which operates one of the largest clinical laboratory networks in the world; Quest Diagnostics Inc., which is a clinical laboratory; and Syneos Health, which is a major clinical research organization.
OMCL | VHIBF | OMCL / VHIBF | |
Capitalization | 1.42B | 578M | 245% |
EBITDA | 99M | 12.3M | 805% |
Gain YTD | -30.750 | 32.648 | -94% |
P/E Ratio | 61.66 | 177.17 | 35% |
Revenue | 1.14B | 75M | 1,515% |
Total Cash | 399M | 91.2M | 438% |
Total Debt | 386M | 784K | 49,235% |
OMCL | ||
---|---|---|
OUTLOOK RATING 1..100 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 88 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 90 | |
PRICE GROWTH RATING 1..100 | 58 | |
P/E GROWTH RATING 1..100 | 96 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OMCL | VHIBF | |
---|---|---|
RSI ODDS (%) | 4 days ago67% | 4 days ago43% |
Stochastic ODDS (%) | 4 days ago76% | 4 days ago45% |
Momentum ODDS (%) | 4 days ago65% | N/A |
MACD ODDS (%) | 4 days ago67% | 4 days ago53% |
TrendWeek ODDS (%) | 4 days ago76% | 4 days ago45% |
TrendMonth ODDS (%) | 4 days ago73% | 4 days ago53% |
Advances ODDS (%) | 6 days ago69% | 20 days ago78% |
Declines ODDS (%) | 4 days ago78% | N/A |
BollingerBands ODDS (%) | 4 days ago71% | 4 days ago57% |
Aroon ODDS (%) | 4 days ago77% | 4 days ago70% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
ICEVX | 45.24 | 0.19 | +0.42% |
NYLI Epoch International Choice Class A | |||
GSCTX | 12.85 | 0.03 | +0.23% |
Goldman Sachs Small Cp Val Insghts C | |||
HBLAX | 14.80 | 0.03 | +0.20% |
Hartford Balanced Income A | |||
LZFIX | 9.33 | -0.02 | -0.21% |
Lazard Equity Franchise Inst Shr | |||
MGLCX | 16.29 | -0.07 | -0.43% |
MFS Global Real Estate C |
A.I.dvisor indicates that over the last year, OMCL has been loosely correlated with CWAN. These tickers have moved in lockstep 38% of the time. This A.I.-generated data suggests there is some statistical probability that if OMCL jumps, then CWAN could also see price increases.
Ticker / NAME | Correlation To OMCL | 1D Price Change % | ||
---|---|---|---|---|
OMCL | 100% | -0.64% | ||
CWAN - OMCL | 38% Loosely correlated | +4.95% | ||
WEAV - OMCL | 35% Loosely correlated | -2.32% | ||
HSTM - OMCL | 35% Loosely correlated | +0.15% | ||
PRVA - OMCL | 33% Loosely correlated | +5.48% | ||
ACIW - OMCL | 32% Poorly correlated | +1.85% | ||
More |
A.I.dvisor tells us that VHIBF and NEXOF have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VHIBF and NEXOF's prices will move in lockstep.
Ticker / NAME | Correlation To VHIBF | 1D Price Change % | ||
---|---|---|---|---|
VHIBF | 100% | +4.56% | ||
NEXOF - VHIBF | 22% Poorly correlated | +11.49% | ||
EMCHF - VHIBF | 21% Poorly correlated | N/A | ||
OMCL - VHIBF | 21% Poorly correlated | -0.64% | ||
XTKG - VHIBF | 20% Poorly correlated | -21.94% | ||
IFBD - VHIBF | 10% Poorly correlated | N/A | ||
More |